RöjmarkS, BloomG, ChouMCY, FieldJB. Hepatic extraction of exogenous insulin and glucagon in the dog. Endocrinology1978; 102: 806–13.
2.
RasmussenSM, HedingLG, ParbstE.Serum IRI in insulin-treated diabetics during a 24-hour period. Diabetologia1975; 11: 151–8.
3.
WertherGA, JenkinsPA, TurnerRC, Twenty-four hour metabolic profiles in diabetic children receiving insulin injections once or twice daily. Br Med J1980; 2: 414–8.
4.
DuffGL, BrechlinDJH, FinkelsteinWE. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. I. The inhibition of experimental cholesterol atherosclerosis in alloxan diabetes. II. The effect of alloxan diabetes on the retrogression of experimental cholesterol atherosclerosis. J Exp Med1949; 89: 611–30.
5.
StamlerJ, PickR, KatzLN. Effect of insulin in the induction and regression of atherosclerosis in the chick. Circ Res1960; 8: 572–6.
6.
CruzAB, AmatuzioDS, GrandeF, Effect of intraarterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ Res1961; 9: 39–43.
7.
EschwegeE, RichardJL, ThibultN, Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris prospective study, ten years later. Horm Metab Rs (Suppl 15)1985: 14–46.
8.
BondyPK, FeligP.Relation of diabetic control to the development of vascular complications. Med Clin North Am1971; 55: 889–97.
9.
JobD, EschwegeE, Guyot-ArgentenC, Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes1976; 25: 463–9.
10.
Steno Study Group: effect of six months of strict metabolic control on eye and kidney function in insulin-dependent diabetes with background retinopathy. Lancet1982; 1: 121–4.
11.
LauritzenT, Frost-LarsenK, LarsenHW, DeckertT.Steno Study Group: effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetes. Lancet1983; 1: 200–4.
12.
Brinchmann-HansenO, Dahl-JorgensenK, HanssenKF, SandvikL.Oslo Study Group: effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol1985; 100: 644–53.
13.
The Kroc Collaborative Study Group: blood glucose control and the evolution of diabetic retinopathy and albuminuria: apreliminary multicenter trial. N Eng J Med1984; 311: 365–72.
14.
TattersallRB, FajansSS. A difference between the inheritance of classical juvenile onset and maturity onset type diabetes of young people. Diabetes1975; 24: 44–53.
15.
FajansSS. Heterogeneity between various families with non-insulin dependent diabetes of MODY type. In: KobberlingJ, TattersallRB, eds. Genetics of Diabetes Mellitis.London and New York: Academic Press, 1982: 251–60.
16.
VibertiGC, WisemanMJ. The kidney in diabetes: Significance of early abnormalities. Clin Endocrinol Metab1986; 15: 753–82.
17.
HolmanRR, DornanTL, Maynon-WhiteV, Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients: a two year randomized prospective study. Lancet1983; 1: 204–8.
18.
VibertiGC, BilousRW, MackintoshD, BendingJJ, KeenH.Longterm correction of hyperglycaemia of renal failure in insulin dependent diabetes. Br Med J (Clin Res)1983; 286: 598–602.
19.
The DCCT Research Group: Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes justified? The Diabetes Control and Complications Trial. N Eng J Med1988; 318: 246–50.
20.
BrennerBM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int1983; 23: 647–55.
21.
Del CastilloER, FuenzalidaR, UrangaJ.Increased glomerular filtration and glomerulopressin activity in diabetic dogs. Horm Met Res1977; 9: 46–53.
22.
UrangaJ, FuenzalidaR, RapoportAL, Effect of glucagon and glomerulopressin on renal function of the dog. Horm Metab Res1979; 11: 275–9.
MullenY, Clare-SalzlerM, SteinE, ClarkW.Islet transplantation for the cure of diabetes. Pancreas1989; 4: 123–35.
25.
SaffranM, FieldJB, PenaJ, JonesRH, OkudaY.Oral delivery of insulin in pancreatectomized diabetic dogs (Abstract). Program of the American Diabetes Association, Michigan 410, 1989: 81.
26.
GwinupG, EliasAN, DomuratES. Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules (submitted for publication).